Pharm-Olam is now Allucent.
Learn More
Investigators
Events
Contact Us
Solutions
Capabilities
Early Phase
Phase 2-3
Phase 4 / Post Marketing
Rescue Study Services
Services
Regulatory Affairs
Study Feasibility
Project Management
Site Activation
Patient Recruitment
Data Management
Medical Affairs
Pharmacovigilance
Biostatistics
Medical Writing
Compliance & Training
Clinical Monitoring and Operations
GDPR - Data Protection
US Gov. Federal Research Services
Expeditionary CRO
Therapeutic Expertise
Rare & Orphan Disease
Infectious Disease & Vaccine
Oncology-Hematology
Allergy
Autoimmune
Global Coverage
About
Our History
Leadership Team
Board of Directors
In the News
Insights
Case Studies
Whitepapers
Blog
Careers
Request a Proposal
Solutions
Capabilities
Early Phase
Phase 2-3
Phase 4 / Post Marketing
Rescue Study Services
Services
Regulatory Affairs
Study Feasibility
Project Management
Site Activation
Patient Recruitment
Data Management
Medical Affairs
Pharmacovigilance
Biostatistics
Medical Writing
Compliance & Training
Clinical Monitoring and Operations
GDPR - Data Protection
US Gov. Federal Research Services
Expeditionary CRO
Therapeutic Expertise
Rare & Orphan Disease
Infectious Disease & Vaccine
Oncology-Hematology
Allergy
Autoimmune
Global Coverage
About
Our History
Leadership Team
Board of Directors
In the News
Insights
Case Studies
Whitepapers
Blog
Careers
Investigators
Events
Contact Us
Request a Proposal
Board of Directors
Guidance That Creates a Healthier World
Mike Cannizzaro
Chairman
Robert J. Davie, Ph.D.
Chief Executive Officer
Elizabeth Garner, MD, MPH
Board Member
G Stephen DeCherney, MD, MPH
Board Member
John Sordillo
Board Member
Pharm-Olam is a privately-held company.